FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Northwind Pharmaceuticals Sulfamethoxazole and Trimethoprim Tablets Recall

Sulfamethoxazole and Trimethoprim Tablets, USP 800mg / 160mg Double Strength packaged i…

Northwind Pharmaceuticals LLC · Indianapolis, IN

Risk level
Class II
Reported by FDA
Sep 24, 2025
Recall ID
D-0654-2025
Check your lot numberHow we source this data

Summary

Northwind Pharmaceuticals recalled Sulfamethoxazole and Trimethoprim Tablets starting Aug 20, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0654-2025 on Sep 24, 2025. Reason: Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets. Status: Ongoing.

Why it was recalled

Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

Product description

Sulfamethoxazole and Trimethoprim Tablets, USP 800mg / 160mg Double Strength packaged in a) 6-count bottles (NDC 51655-307-87), b) 10-count bottles (NDC 51655-307-53), c) 14-count bottles (NDC 51655-307-84), d) 20-count bottles (NDC 51655-307-20) Rx Only, Repackaged from Amneal Pharmaceuticals LLC. Repackaged by: Northwind Pharmaceuticals, Indianapolis, IN 46203.

Lot numbers, UPCs & expiration codes

Lot #: a) F118062503, Exp Date 05/31/2027, F118062507, Exp Date. 07/31/2027. b) F118062504, F118062505, Exp. Date 05/31/2027; F118062509, Exp. Date. 08/31/2027; F118062512, Exp. Date 04/30/2027. c) F118062506, Exp. Date 06/30/2027. d) F118062423, Exp. Date 01/31/2027; F118062501, Exp. Date 06/30/2027; F118062502, Exp. Date 04/30/2027; F118062508, Exp. Date 08/31/2027.

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0654-2025
Classification
Class II
Status
Ongoing
Recall initiated
Aug 20, 2025
FDA report date
Sep 24, 2025
Quantity
a) 96 bottles, b) 627 bottles, c) 428 bottles, d) 1144 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Northwind Pharmaceuticals LLC

Original FDA data

Every field from FDA enforcement report D-0654-2025, exactly as published.

Show all FDA fields
City
Indianapolis
State
IN
Status
Ongoing
Country
United States
Event ID
97544
Address
4838 Fletcher Ave Ste 1000
Code information
Lot #: a) F118062503, Exp Date 05/31/2027, F118062507, Exp Date. 07/31/2027. b) F118062504, F118062505, Exp. Date 05/31/2027; F118062509, Exp. Date. 08/31/2027; F118062512, Exp. Date 04/30/2027. c) F118062506, Exp. Date 06/30/2027. d) F118062423, Exp. Date 01/31/2027; F118062501, Exp. Date 06/30/2027; F118062502, Exp. Date 04/30/2027; F118062508, Exp. Date 08/31/2027.
Postal code
46203-1642
Report date
Sep 24, 2025
Product type
Drugs
Recall number
D-0654-2025
Classification
Class II
Recalling firm
Northwind Pharmaceuticals LLC
Product quantity
a) 96 bottles, b) 627 bottles, c) 428 bottles, d) 1144 bottles
Reason for recall
Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sulfamethoxazole and Trimethoprim Tablets, USP 800mg / 160mg Double Strength packaged in a) 6-count bottles (NDC 51655-307-87), b) 10-count bottles (NDC 51655-307-53), c) 14-count bottles (NDC 51655-307-84), d) 20-count bottles (NDC 51655-307-20) Rx Only, Repackaged from Amneal Pharmaceuticals LLC. Repackaged by: Northwind Pharmaceuticals, Indianapolis, IN 46203.
Distribution pattern
Nationwide within the United States
Recall initiation date
Aug 20, 2025
Initial firm notification
Letter
Center classification date
Sep 17, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0654-2025, published Sep 24, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls